Kazia Therapetcs ADR (KZIA)
followers
·
Follow
Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
James S. Garner
Employees:
12
THREE INTERNATIONAL TOWERS LEVEL 24,, 300 BARANGAROO AVENUE, SYDNEY NSW, C3, 2000
01161298780088
-
Formally known as:
- Novogen Limited
- NOVOGEN LTD SPONS ADR (NEW)
| Date | Ratio |
|---|---|
| 2012-01-03 | 1:5 |
| 2013-01-28 | 3038:1000 |
| 2017-07-14 | 1:4 |
Kazia Therapeutics Limited is an oncology-focused biotechnology company. Its lead development candidate is Paxalisib, a small molecule, brain-penetrant inhibitor of the PI3K/Akt/mTor pathway. It is also developing EVT801, an investigational new drug for various forms of cancer.
| All 13F Filers | Prior | Change | Hedge Funds 1 | Prior | Change |
|---|